Thus, Smad7 specifically expressed by CD4+ T cells may play a role in the pathogenesis of RA by rebalancing the Th17/Treg immune response via by inhibiting TGF-β/Smad3 signaling, which requires further investigation. This evidence concerns the gene SMAD3 and rheumatoid arthritis.